Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Citations illustrating the prohibitions linked to the resting period after treatment.

Alain Mpanya (267142)
David Hendrickx (334959)
Mimy Vuna (334963)
Albert Kanyinda (334967)
Crispin Lumbala (334969)
Valéry Tshilombo (334970)
Patrick Mitashi (116126)
Oscar Luboya (334972)
Victor Kande (116136)
Marleen Boelaert (56961)
Pierre Lefèvre (334974)
Pascal Lutumba (116142)

Publication date

February 2013

DOI

10.1371/journal.pntd.0001467.t003

Abstract

<p>Citations illustrating the prohibitions linked to the resting period after treatment.</p

Extracted data

Related items

An overview of the interventions, their target groups, periods of dissemination.

Anna T. van ‘t Noordende (6560531)
Suchitra Lisam (6560534)
Vivek Singh (71183)
Atif Sadiq (10017792)
Ashok Agarwal (325619)
Duane C. Hinders (11320828)
Jan Hendrik Richardus (7180829)
Wim H. van Brakel (8072069)
Ida J. Korfage (9640614)

August 2021

An overview of the interventions, their target groups, periods of dissemination.</p

Treatments administered by each study and respective study characteristics for included efficacy studies.

Marta S. Palmeirim (4451587)
Eveline Hürlimann (217729)
Stefanie Knopp (108848)
Benjamin Speich (159922)
Vicente Belizario Jr. (5150756)
Serene A. Joseph (673044)
Michel Vaillant (39101)
Piero Olliaro (35337)
Jennifer Keiser (39606)

April 2018

<p>Treatments administered by each study and respective study characteristics for included efficacy ...

Illustration of daily exposure status defined by receipt of an aggressive regimen in the 14 days prior (example of three patients assessed at day 44 of treatment).

Dylan B. Tierney (631722)
Molly F. Franke (222882)
Mercedes C. Becerra (139368)
Félix A. Alcántara Virú (5660662)
César A. Bonilla (5660665)
Epifanio Sánchez (5660668)
Dalia Guerra (398735)
Maribel Muñoz (398744)
Karim Llaro (398740)
Eda Palacios (398745)
Lorena Mestanza (398742)
Rocío M. Hurtado (5660671)
Jennifer J. Furin (370221)
Sonya Shin (509484)
Carole D. Mitnick (94953)

September 2014

<p>Illustration of daily exposure status defined by receipt of an aggressive regimen in the 14 days ...

Treatment of strictures after contrast study (NEC cases treated medically during the acute phase).

Aurélie Gaudin (469663)
Caroline Farnoux (469664)
Arnaud Bonnard (35748)
Marianne Alison (469665)
Laure Maury (469666)
Valérie Biran (259556)
Olivier Baud (112799)

October 2013

<p>Treatment of strictures after contrast study (NEC cases treated medically during the acute phase)...

Overview of the twice daily treatment regimen in the two experimental periods.

Christina Pedersen (4984640)
Trine Porsgaard (4984634)
Maria Thomsen (615501)
Mette Marie Rosenkilde (2142424)
Nikolaj Kulahin Roed (4984637)

March 2018

<p>Overview of the twice daily treatment regimen in the two experimental periods.</p

The Effect of Prohibition on Alcohol Consumption: Evidence from Drunkenness Arrests

Rand Corporation
Mireille Jacobson
Angela K. Dillsa
Mireille Jacobsonb
Jeffrey A. Mironc

January 2004

The effect of alcohol prohibition on alcohol consumption: evidence from drunkenness arrest

Literature review of clinical trials treating patients with weekly primaquine regimens.

Walter R. J. Taylor (8537583)
Niamh Meagher (10905688)
Benedikt Ley (148722)
Kamala Thriemer (148725)
Germana Bancone (34875)
Ari Satyagraha (16943021)
Ashenafi Assefa (776696)
Krisin Chand (16939310)
Nguyen Hoang Chau (13744510)
Mehul Dhorda (351592)
Tamiru S. Degaga (16943024)
Lenny L. Ekawati (14241842)
Asrat Hailu (59005)
Mohammad Anwar Hasanzai (16939316)
Mohammad Nader Naddim (16939313)
Ayodhia Pitaloka Pasaribu (8842943)
Awab Ghulam Rahim (13744507)
Inge Sutanto (391795)
Ngo Viet Thanh (16943027)
Nguyen Thi Tuyet-Trinh (16943030)
Naomi Waithira (8188137)
Adugna Woyessa (802684)
Arjen Dondorp (229103)
Lorenz von Seidlein (45473)
Julie A. Simpson (242873)
Nicholas J. White (35779)
J. Kevin Baird (7464932)
Nicholas P. Day (12366670)
Ric N. Price (7464974)

September 2023

Literature review of clinical trials treating patients with weekly primaquine regimens.</p

Incidence of adverse events during on-treatment follow-up and whole study period.

Young-Jun Rhie (6708275)
Jae-Ho Yoo (6708278)
Jin-Ho Choi (288185)
Hyun-Wook Chae (6708281)
Jae Hyun Kim (665252)
Sochung Chung (6708284)
Il Tae Hwang (6708287)
Choong Ho Shin (841540)
Eun Young Kim (132204)
Ho-Seong Kim (286495)

May 2019

Incidence of adverse events during on-treatment follow-up and whole study period.</p

Ascertainment of subsequent episodes of re-treatment via record linkage and manual review for the study.

Florian M. Marx (305940)
Rory Dunbar (305942)
Donald A. Enarson (257339)
Nulda Beyers (305944)

February 2013

<p>Ascertainment of subsequent episodes of re-treatment via record linkage and manual review for the...

Description of the therapeutic exercises used in the interventions of the trials included in this systematic review.

Renato S. Melo (11921454)
Caroline Stefany Ferreira Cardeira (16955702)
Damaris Scarleth A. Rezende (16955705)
Vinícius J. Guimarães-do-Carmo (16955708)
Andrea Lemos (7453763)
Alberto Galvão de Moura-Filho (16955711)

September 2023

Description of the therapeutic exercises used in the interventions of the trials included in this sy...

Placebo treatments were referred to less frequently than target treatments.

Felicity L. Bishop (317940)
Alison E. M. Adams (317941)
Ted J. Kaptchuk (234474)
George T. Lewith (317942)

February 2013

<p>Placebo treatments were referred to less frequently than target treatments.</p

Attributes and levels assigned to preventive treatments currently under study.

Mark Harrison (4222480)
Luke Spooner (3545009)
Nick Bansback (185069)
Katherine Milbers (6635777)
Cheryl Koehn (5950853)
Kam Shojania (6635780)
Axel Finckh (3918683)
Marie Hudson (289434)

April 2019

Attributes and levels assigned to preventive treatments currently under study.</p

Summary of studies on the impact of smoke-free legislation on symptomatology.

Yolanda Rando-Matos (4288084)
Mariona Pons-Vigués (529281)
María José López (4288078)
Rodrigo Córdoba (4288072)
José Luis Ballve-Moreno (4288063)
Elisa Puigdomènech-Puig (4288066)
Vega Estíbaliz Benito-López (4288087)
Olga Lucía Arias-Agudelo (4288093)
Mercè López-Grau (4288081)
Anna Guardia-Riera (4288075)
José Manuel Trujillo (4288090)
Carlos Martin-Cantera (4288069)

July 2017

<p>Summary of studies on the impact of smoke-free legislation on symptomatology.</p

Treatment parameters of the two study groups at the baseline and during follow-up period.

Luciano A. Pedrini (6392159)
Adam M. Zawada (847589)
Anke C. Winter (6392162)
Jenny Pham (6392165)
Gudrun Klein (6392168)
Melanie Wolf (3103785)
Astrid Feuersenger (6392171)
Pio Ruggiero (6392174)
Annalisa Feliciani (6392177)
Carlo Barbieri (848258)
Adelheid Gauly (355519)
Bernard Canaud (177330)
Stefano Stuard (2552848)

February 2019

Treatment parameters of the two study groups at the baseline and during follow-up period.</p

Summary of meta-analyses analyzing adjuvants for analgesia/block duration.

Meghan A. Kirksey (793928)
Stephen C. Haskins (793929)
Jennifer Cheng (793930)
Spencer S. Liu (793931)

September 2015

<p>Abbreviations: LA = local anesthetic; OR = odds ratio</p><p>Summary of meta-analyses analyzing ad...

An overview of the interventions, their target groups, periods of dissemination.

Anna T. van ‘t Noordende (6560531)
Suchitra Lisam (6560534)
Vivek Singh (71183)
Atif Sadiq (10017792)
Ashok Agarwal (325619)
Duane C. Hinders (11320828)
Jan Hendrik Richardus (7180829)
Wim H. van Brakel (8072069)
Ida J. Korfage (9640614)

August 2021

An overview of the interventions, their target groups, periods of dissemination.</p

Treatments administered by each study and respective study characteristics for included efficacy studies.

Marta S. Palmeirim (4451587)
Eveline Hürlimann (217729)
Stefanie Knopp (108848)
Benjamin Speich (159922)
Vicente Belizario Jr. (5150756)
Serene A. Joseph (673044)
Michel Vaillant (39101)
Piero Olliaro (35337)
Jennifer Keiser (39606)

April 2018

<p>Treatments administered by each study and respective study characteristics for included efficacy ...

Illustration of daily exposure status defined by receipt of an aggressive regimen in the 14 days prior (example of three patients assessed at day 44 of treatment).

Dylan B. Tierney (631722)
Molly F. Franke (222882)
Mercedes C. Becerra (139368)
Félix A. Alcántara Virú (5660662)
César A. Bonilla (5660665)
Epifanio Sánchez (5660668)
Dalia Guerra (398735)
Maribel Muñoz (398744)
Karim Llaro (398740)
Eda Palacios (398745)
Lorena Mestanza (398742)
Rocío M. Hurtado (5660671)
Jennifer J. Furin (370221)
Sonya Shin (509484)
Carole D. Mitnick (94953)

September 2014

<p>Illustration of daily exposure status defined by receipt of an aggressive regimen in the 14 days ...

Treatment of strictures after contrast study (NEC cases treated medically during the acute phase).

Aurélie Gaudin (469663)
Caroline Farnoux (469664)
Arnaud Bonnard (35748)
Marianne Alison (469665)
Laure Maury (469666)
Valérie Biran (259556)
Olivier Baud (112799)

October 2013

<p>Treatment of strictures after contrast study (NEC cases treated medically during the acute phase)...

Overview of the twice daily treatment regimen in the two experimental periods.

Christina Pedersen (4984640)
Trine Porsgaard (4984634)
Maria Thomsen (615501)
Mette Marie Rosenkilde (2142424)
Nikolaj Kulahin Roed (4984637)

March 2018

<p>Overview of the twice daily treatment regimen in the two experimental periods.</p

The Effect of Prohibition on Alcohol Consumption: Evidence from Drunkenness Arrests

Rand Corporation
Mireille Jacobson
Angela K. Dillsa
Mireille Jacobsonb
Jeffrey A. Mironc

January 2004

The effect of alcohol prohibition on alcohol consumption: evidence from drunkenness arrest

Literature review of clinical trials treating patients with weekly primaquine regimens.

Walter R. J. Taylor (8537583)
Niamh Meagher (10905688)
Benedikt Ley (148722)
Kamala Thriemer (148725)
Germana Bancone (34875)
Ari Satyagraha (16943021)
Ashenafi Assefa (776696)
Krisin Chand (16939310)
Nguyen Hoang Chau (13744510)
Mehul Dhorda (351592)
Tamiru S. Degaga (16943024)
Lenny L. Ekawati (14241842)
Asrat Hailu (59005)
Mohammad Anwar Hasanzai (16939316)
Mohammad Nader Naddim (16939313)
Ayodhia Pitaloka Pasaribu (8842943)
Awab Ghulam Rahim (13744507)
Inge Sutanto (391795)
Ngo Viet Thanh (16943027)
Nguyen Thi Tuyet-Trinh (16943030)
Naomi Waithira (8188137)
Adugna Woyessa (802684)
Arjen Dondorp (229103)
Lorenz von Seidlein (45473)
Julie A. Simpson (242873)
Nicholas J. White (35779)
J. Kevin Baird (7464932)
Nicholas P. Day (12366670)
Ric N. Price (7464974)

September 2023

Literature review of clinical trials treating patients with weekly primaquine regimens.</p

Incidence of adverse events during on-treatment follow-up and whole study period.

Young-Jun Rhie (6708275)
Jae-Ho Yoo (6708278)
Jin-Ho Choi (288185)
Hyun-Wook Chae (6708281)
Jae Hyun Kim (665252)
Sochung Chung (6708284)
Il Tae Hwang (6708287)
Choong Ho Shin (841540)
Eun Young Kim (132204)
Ho-Seong Kim (286495)

May 2019

Incidence of adverse events during on-treatment follow-up and whole study period.</p

Ascertainment of subsequent episodes of re-treatment via record linkage and manual review for the study.

Florian M. Marx (305940)
Rory Dunbar (305942)
Donald A. Enarson (257339)
Nulda Beyers (305944)

February 2013

<p>Ascertainment of subsequent episodes of re-treatment via record linkage and manual review for the...

Description of the therapeutic exercises used in the interventions of the trials included in this systematic review.

Renato S. Melo (11921454)
Caroline Stefany Ferreira Cardeira (16955702)
Damaris Scarleth A. Rezende (16955705)
Vinícius J. Guimarães-do-Carmo (16955708)
Andrea Lemos (7453763)
Alberto Galvão de Moura-Filho (16955711)

September 2023

Description of the therapeutic exercises used in the interventions of the trials included in this sy...

Placebo treatments were referred to less frequently than target treatments.

Felicity L. Bishop (317940)
Alison E. M. Adams (317941)
Ted J. Kaptchuk (234474)
George T. Lewith (317942)

February 2013

<p>Placebo treatments were referred to less frequently than target treatments.</p

Attributes and levels assigned to preventive treatments currently under study.

Mark Harrison (4222480)
Luke Spooner (3545009)
Nick Bansback (185069)
Katherine Milbers (6635777)
Cheryl Koehn (5950853)
Kam Shojania (6635780)
Axel Finckh (3918683)
Marie Hudson (289434)

April 2019

Attributes and levels assigned to preventive treatments currently under study.</p

Summary of studies on the impact of smoke-free legislation on symptomatology.

Yolanda Rando-Matos (4288084)
Mariona Pons-Vigués (529281)
María José López (4288078)
Rodrigo Córdoba (4288072)
José Luis Ballve-Moreno (4288063)
Elisa Puigdomènech-Puig (4288066)
Vega Estíbaliz Benito-López (4288087)
Olga Lucía Arias-Agudelo (4288093)
Mercè López-Grau (4288081)
Anna Guardia-Riera (4288075)
José Manuel Trujillo (4288090)
Carlos Martin-Cantera (4288069)

July 2017

<p>Summary of studies on the impact of smoke-free legislation on symptomatology.</p

Treatment parameters of the two study groups at the baseline and during follow-up period.

Luciano A. Pedrini (6392159)
Adam M. Zawada (847589)
Anke C. Winter (6392162)
Jenny Pham (6392165)
Gudrun Klein (6392168)
Melanie Wolf (3103785)
Astrid Feuersenger (6392171)
Pio Ruggiero (6392174)
Annalisa Feliciani (6392177)
Carlo Barbieri (848258)
Adelheid Gauly (355519)
Bernard Canaud (177330)
Stefano Stuard (2552848)

February 2019

Treatment parameters of the two study groups at the baseline and during follow-up period.</p

Summary of meta-analyses analyzing adjuvants for analgesia/block duration.

Meghan A. Kirksey (793928)
Stephen C. Haskins (793929)
Jennifer Cheng (793930)
Spencer S. Liu (793931)

September 2015

<p>Abbreviations: LA = local anesthetic; OR = odds ratio</p><p>Summary of meta-analyses analyzing ad...

An overview of the interventions, their target groups, periods of dissemination.

Anna T. van ‘t Noordende (6560531)
Suchitra Lisam (6560534)
Vivek Singh (71183)
Atif Sadiq (10017792)
Ashok Agarwal (325619)
Duane C. Hinders (11320828)
Jan Hendrik Richardus (7180829)
Wim H. van Brakel (8072069)
Ida J. Korfage (9640614)

August 2021

An overview of the interventions, their target groups, periods of dissemination.</p

Treatments administered by each study and respective study characteristics for included efficacy studies.

Marta S. Palmeirim (4451587)
Eveline Hürlimann (217729)
Stefanie Knopp (108848)
Benjamin Speich (159922)
Vicente Belizario Jr. (5150756)
Serene A. Joseph (673044)
Michel Vaillant (39101)
Piero Olliaro (35337)
Jennifer Keiser (39606)

April 2018

<p>Treatments administered by each study and respective study characteristics for included efficacy ...

Illustration of daily exposure status defined by receipt of an aggressive regimen in the 14 days prior (example of three patients assessed at day 44 of treatment).

Dylan B. Tierney (631722)
Molly F. Franke (222882)
Mercedes C. Becerra (139368)
Félix A. Alcántara Virú (5660662)
César A. Bonilla (5660665)
Epifanio Sánchez (5660668)
Dalia Guerra (398735)
Maribel Muñoz (398744)
Karim Llaro (398740)
Eda Palacios (398745)
Lorena Mestanza (398742)
Rocío M. Hurtado (5660671)
Jennifer J. Furin (370221)
Sonya Shin (509484)
Carole D. Mitnick (94953)

September 2014

<p>Illustration of daily exposure status defined by receipt of an aggressive regimen in the 14 days ...